Get the latest tech news
FDA employees say the agency's Elsa generative AI hallucinates entire studies
The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.
The CNN investigation highlighting these flaws with the FDA's artificial intelligence arrived on the same day as the White House introduced an " AI Action Plan." The program presented AI development as a technological arms race that the US should win at all costs, and it laid out plans to remove "red tape and onerous regulation" in the sector. Considering each of thosethreetopics has a documented impact on public health, the ability of tools like Elsa to provide genuine benefits to both the FDA and to US patients looks increasingly doubtful.
Or read this on Endgadget
